Security file · CUSIP 126650100
CVS
CVS HEALTH CORP · US listing · held by 7 tracked managers in Q3 2026.
Tracked holders · Q3 2026
7
-3 vs Q2 2026
Aggregate reported value
$6.23B
sum of holders' reported positions
New holders this quarter
0
2 added · 3 trimmed
Holder return since filing
-0.8%
weighted by each holder's position share · since filing
Ownership · Q3 2026
| Manager | Weight | Shares | Δ shares | Entry | Return | Value | Activity | |
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox Fundsfiled 13 Nov ET | 2.11% | 46.04M | -7.9% | $89 | -1.2% | $3.95B | Trimmed |
| 2 | Christopher Davis - Davis Advisorsfiled 10 Nov ET | 4.40% | 11.90M | +0.3% | $89 | -0.8% | $1.02B | Added |
| 3 | Richard Pzena - Pzena Investment Managementfiled 30 Oct ET | 2.59% | 10.30M | -12.5% | $90 | -2.1% | $882M | Trimmed |
| 4 | Prem Watsa - Fairfax Financial Holdingsfiled 16 Nov ET | 8.78% | 2.71M | +0.0% | $88 | +0.0% | $232M | Held |
| 5 | Samantha McLemore - Patient Capital Managementfiled 12 Nov ET | 2.64% | 970K | -21.5% | $90 | -1.6% | $83.12M | Trimmed |
| 6 | John Rogers - Ariel Investmentsfiled 13 Nov ET | 0.74% | 825K | +13.0% | $89 | -1.2% | $70.68M | Added |
| 7 | David Katz - Matrix Asset Advisorsfiled 13 Oct ET | 0.04% | 6,175 | +0.0% | $87 | +1.6% | $529K | Held |
Holder count
Aggregate reported value
Quarterly aggregation
| Quarter | Holders | Δ holders | Aggregate value | Total shares |
|---|---|---|---|---|
| Q3 2026 | 7 | -3 | $6.23B | 72.75M |
| Q2 2026 | 10 | +1 | $8.52B | 82.39M |
| Q1 2026 | 9 | +0 | $5.87B | 81.80M |
| Q4 2025 | 9 | +1 | $7.54B | 95.00M |
| Q3 2025 | 8 | +0 | $7.99B | 105.93M |
| Q2 2025 | 8 | -1 | $6.27B | 90.94M |
| Q1 2025 | 9 | +1 | $7.71B | 113.85M |
| Q4 2024 | 8 | +2 | $4.96B | 110.58M |
| Q3 2024 | 6 | +1 | $4.54B | 72.25M |
| Q2 2024 | 5 | +1 | $3.78B | 64.01M |
| Q1 2024 | 4 | +1 | $3.35B | 42.02M |
| Q4 2023 | 3 | -3 | $2.75B | 34.78M |
| Q3 2023 | 6 | +2 | $2.19B | 31.30M |
| Q2 2023 | 4 | +3 | $1.19B | 17.15M |
| Q1 2023 | 1 | — | $514K | 6,918 |